Avidity Biosciences Ownership | Who Owns Avidity Biosciences?

Overview Forecast RevenueFinancials Chart

Avidity Biosciences Ownership Summary

Avidity Biosciences is owned by 128.39% institutional investors, 4.83% insiders. Fmr is the largest institutional shareholder, holding 18.53% of RNA shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 4.13% of its assets in Avidity Biosciences shares.

RNA Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Avidity Biosciences	128.39%	4.83%	-33.22%
Sector	Healthcare Stocks	47.31%	8.01%	44.69%
Industry	Biotech Stocks	45.43%	7.81%	46.75%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Fmr	16.16M	18.53%	$660.10M
Price t rowe associates inc /md/	10.92M	12.52%	$445.94M
Rtw investments, lp	8.81M	10.10%	$359.76M
Blackrock	8.62M	9.89%	$352.23M
Avoro capital advisors	6.50M	7.46%	$265.73M
Vanguard group	5.94M	6.82%	$242.80M
Ra capital management	5.40M	6.19%	$220.61M
Wellington management group llp	3.80M	4.36%	$155.31M
Janus henderson group	3.66M	4.19%	$149.49M
Adage capital partners gp	3.40M	3.90%	$138.77M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Alethea capital management	503.50K	15.61%	$20.57M
Casdin capital	2.08M	6.50%	$85.17M
Rtw investments, lp	8.81M	5.57%	$359.76M
Silverarc capital management	517.73K	4.99%	$21.15M
Propel bio management	178.50K	4.73%	$7.29M
Boxer capital	1.73M	3.72%	$70.56M
Avoro capital advisors	6.50M	3.54%	$265.73M
Ra capital management	5.40M	2.92%	$220.61M
Eam global investors	116.61K	1.07%	$4.76M
Cormorant asset management, lp	425.00K	1.00%	$17.36M

Top Buyers

Holder	Shares	% Assets	Change
Price t rowe associates inc /md/	10.92M	0.05%	3.49M
Wellington management group llp	3.80M	0.03%	2.57M
Blackrock	8.62M	0.01%	2.46M
Janus henderson group	3.66M	0.08%	2.41M
Ra capital management	5.40M	2.92%	2.12M

Top Sellers

Holder	Shares	% Assets	Change
Cowen and company	-	-	-5.13M
5am venture management	-	-	-665.55K
Farallon capital management	5.00K	0.00%	-601.06K
Artisan partners limited partnership	1.90M	0.12%	-424.44K
Jpmorgan chase	481.48K	0.00%	-411.99K

New Positions

Holder	Shares	% Assets	Change	Value
Polar capital	1.11M	0.27%	1.11M	$45.51M
Artal group	655.55K	0.68%	655.55K	$26.78M
Cormorant asset management, lp	425.00K	1.00%	425.00K	$17.36M
Lord, abbett	414.34K	0.05%	414.34K	$16.93M
Eventide asset management	375.92K	0.26%	375.92K	$15.36M

Sold Out

Holder	Change
Hollencrest capital management	-10.00
Nelson, van denburg & campbell wealth management group	-15.00
Innealta capital	-49.00
Twin tree management, lp	-206.00
Itau unibanco	-426.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	198	22.98%	111,975,611	25.39%	128	1.22%	129	44.94%	49	-
Mar 31, 2024	161	9.52%	89,302,004	17.64%	102	0.95%	89	14.10%	49	6.52%
Dec 31, 2023	147	2.08%	75,911,779	-7.12%	103	0.85%	78	-2.50%	46	17.95%
Sep 30, 2023	144	-	81,728,343	-0.85%	110	0.83%	80	-9.09%	39	18.18%
Jun 30, 2023	144	2.13%	82,429,126	8.59%	115	0.99%	88	-3.30%	33	26.92%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Growth Compy Commingled Pl S	4.89M	4.13%	28.06K
Fidelity Growth Compy Commingled Pl O	4.86M	4.11%	-69.00K
US Small-Cap Growth II Equity Comp	4.48M	3.79%	168.08K
T. Rowe Price New Horizons	4.48M	3.79%	-14.11K
Vanguard Total Stock Mkt Idx Inv	3.53M	2.98%	3.12K
Fidelity Growth Company Fund	3.52M	2.98%	-7.48K
iShares Russell 2000 ETF	2.78M	2.33%	-6.24K
T. Rowe Price Health Sciences	2.56M	2.16%	-79.43K
Vanguard Health Care Inv	2.35M	1.99%	1.62M
SPDR® S&P Biotech ETF	2.20M	1.86%	24.32K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Nov 06, 2024	MacLean Michael F	Chief Financial Officer	Sell	$629.01K
Nov 06, 2024	MacLean Michael F	Chief Financial Officer	Sell	$1.26M
Oct 21, 2024	LEVIN ARTHUR A	-	Sell	$233.17K
Oct 16, 2024	McCarthy Teresa	Chief Human Resources Officer	Sell	$1.21M
Oct 07, 2024	Thompson Tamar	-	Sell	$1.35M

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	6
2024 Q3	-	14
2024 Q2	-	18
2024 Q1	-	12
2023 Q4	-	-

RNA Ownership FAQ

Who Owns Avidity Biosciences?

Avidity Biosciences shareholders are primarily institutional investors at 128.39%, followed by 4.83% insiders and -33.22% retail investors. The average institutional ownership in Avidity Biosciences's industry, Biotech Stocks , is 45.43%, which Avidity Biosciences exceeds.

Who owns the most shares of Avidity Biosciences?

Avidity Biosciences’s largest shareholders are Fmr (16.16M shares, 18.53%), Price t rowe associates inc /md/ (10.92M shares, 12.52%), and Rtw investments, lp (8.81M shares, 10.10%). Together, they hold 41.14% of Avidity Biosciences’s total shares outstanding.

Does Blackrock own Avidity Biosciences?

Yes, BlackRock owns 9.89% of Avidity Biosciences, totaling 8.62M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 352.23M$. In the last quarter, BlackRock increased its holdings by 2.46M shares, a 39.84% change.

Who is Avidity Biosciences’s biggest shareholder by percentage of total assets invested?

Alethea capital management is Avidity Biosciences’s biggest shareholder by percentage of total assets invested, with 15.61% of its assets in 503.5K Avidity Biosciences shares, valued at 20.57M$.

Who is the top mutual fund holder of Avidity Biosciences shares?

Fidelity Growth Compy Commingled Pl S is the top mutual fund holder of Avidity Biosciences shares, with 4.13% of its total shares outstanding invested in 4.89M Avidity Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools